NEUTRA CORP.

NTRR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2023 FY2022 FY2021 FY2020
Revenue $68.0K $92.0K $9.7K $6.4K
Cost of Revenue $32.7K $60.9K $42.9K
Gross Profit $35.3K $31.2K $-33.3K $6.4K
Gross Margin 51.9% 33.9% -343.3% 100.0%
Operating Expenses
Research & Development
SG&A Expense $228.0K $508.5K $414.7K $400.6K
Operating Income $-297.7K $-583.6K $-478.7K $-394.2K
Operating Margin -437.8% -634.2% -4,941.3% -6,164.9%
Interest Expense $62.1K $60.6K $121.6K $340.7K
Pretax Income $-557.9K $-632.9K
Income Tax Expense $3.5K $3.5K $0
Net Income $-561.4K $-632.9K $-538.9K $-695.6K
Net Margin -825.7% -687.9% -5,563.0% -10,877.6%
EPS (Basic) $0.00 $0.00
EPS (Diluted) $0.00 $0.00
Shares Outstanding (Basic) 2.92B 2.21B 1.52B 1.38B
Shares Outstanding (Diluted) 2.92B 2.21B 1.52B 1.38B
Dividends Per Share